INCOME TAXES	6 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	NOTE 10. INCOME TAXES The Company and its non-Canadian subsidiaries file a consolidated U.S. federal income tax return. USCAN and Galileo file separate tax returns in Canada. See income tax information for Galileo in Note 2, Discontinued Operations. Provisions for income taxes include deferred taxes for temporary differences in the bases of assets and liabilities for financial and tax purposes resulting from the use of the liability method of accounting for income taxes. For U.S. federal income tax purposes at December 31, 2020, the Company has no U.S. federal net operating loss carryovers. The Company has capital loss carryovers of $1.0 million with $696,000 and $348,000 expiring in fiscal years 2022 and 2023, respectively. The Company has no charitable contribution carryovers at December 31, 2020. For Canadian income tax purposes, USCAN has no net operating loss carryovers and no capital loss carryovers. A valuation allowance is provided when it is more likely than not that some portion of the deferred tax amount will not be realized. At December 31, 2020, and June 30, 2020, a valuation allowance of $145,000 and $2.8 million, respectively, was included to fully reserve for net operating loss carryovers, other carryovers and certain book/tax differences in the balance sheet.

INCOME TAXES

6 Months Ended

Dec. 31, 2020

NOTE 10. INCOME TAXES

The Company and its non-Canadian subsidiaries file a consolidated U.S. federal income tax return. USCAN and Galileo file separate tax returns in Canada. See income tax information for Galileo in Note 2, Discontinued Operations. Provisions for income taxes include deferred taxes for temporary differences in the bases of assets and liabilities for financial and tax purposes resulting from the use of the liability method of accounting for income taxes.

For U.S. federal income tax purposes at December 31, 2020, the Company has no U.S. federal net operating loss carryovers. The Company has capital loss carryovers of $1.0 million with $696,000 and $348,000 expiring in fiscal years 2022 and 2023, respectively. The Company has no charitable contribution carryovers at December 31, 2020.

For Canadian income tax purposes, USCAN has no net operating loss carryovers and no capital loss carryovers.

A valuation allowance is provided when it is more likely than not that some portion of the deferred tax amount will not be realized. At December 31, 2020, and June 30, 2020, a valuation allowance of $145,000 and $2.8 million, respectively, was included to fully reserve for net operating loss carryovers, other carryovers and certain book/tax differences in the balance sheet.